First results and experience with PRRT in South Africa by Mariza Vorster, M Modiselle, C Corbett, I Lawal, John Buscombe, Mike Sathekge

Subjects: Get full text

Case report: Resolution of VIPoma-related symptoms with peptide receptor radionuclide therapy by Turgut Bora Cengiz, Raksha Kulkarni, Virginia Corbett, Nasrin V. Ghesani, Edward Wolin, Munir V. Ghesani

Subjects: “…PRRT…”
Get full text

Proline‐rich transmembrane protein 2 regulates the magnitude and frequency of dopamine release by repetitive neuronal stimuli in the striatum of L‐dopa‐treated mice by Daisuke Hatta, Shiho Makiya, Kaito Kanamoto, Kaori Watanabe, Yuki Fuchigami, Shigeru Kawakami, Akira Kinoshita, Koh‐Ichiro Yoshiura, Naohiro Kurotaki, Keiro Shirotani, Nobuhisa Iwata

Subjects: Get full text

RM2 and DB15 analogues bearing [177Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative study by Panagiotis Kanellopoulos, Athanasios Bitzios, Ivan Zelepukin, Ekaterina Bezverkhniaia, Theodosia Maina, Berthold A. Nock, Vladimir Tolmachev, Anna Orlova

Subjects: Get full text

Risk of bowel ischemia in patients with mesenteric neuroendocrine tumors after treatment with 177Lu-DOTATATE by Eleonora Pelle, Taymeyah Al-Toubah, Ghassan El-Haddad, Brian Morse, Bhavana Konda, Vineeth Sukrithan, Jonathan Strosberg

Subjects: “…prrt…”
Get full text

Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients receiving peptide receptor radionuclide therapy by Annie Mathew, David Kersting, Wolfgang P. Fendler, Johanna Braegelmann, Dagmar Fuhrer, Harald Lahner

Subjects: Get full text

Pan-cancer analysis reveals PRRT4 is a potential prognostic factor of AML by Wenqiong Xiang, Fangjun Chen, Hao Zhou, Guilin Ren, Guangliang Qiang, Li Wang

Subjects: Get full text

Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy by Tobias Stemann Lau, Tobias Stemann Lau, Tobias Stemann Lau, Lars Bossen, Lars Bossen, Daniel Guldager Kring Rasmussen, Federica Genovese, Morten Karsdal, Anne Kirstine Arveschoug, Anne Kirstine Arveschoug, Henning Grønbæk, Henning Grønbæk, Henning Grønbæk, Gitte Dam, Gitte Dam, Gitte Dam

Subjects: “…PRRT…”
Get full text

A novel germline (c.314T>A) SDHB variant in metastatic paraganglioma: case report and literature review by Stella Bernardi, Stella Bernardi, Stefania Zovato, Gianmaria Pennelli, Marco Cavallaro, Matteo Rovina, Chiara Dobrinja, Chiara Dobrinja, Alessandra Guglielmi, Fabrizio Zanconati, Fabrizio Zanconati, Daniela Mazzà, Alberto Nieri, Mirco Bartolomei, Francesca Schiavi

Subjects: Get full text

Case Report: PRRT in a patient with Zollinger-Ellison syndrome. The management of gastrointestinal complications by Martina Di Franco, Rexhep Durmo, Maria Liberata Di Paolo, Roberto Giacosa, Elisa Bannò, Valentina Ambrosini, Valentina Ambrosini, Angelina Filice

Subjects: Get full text

“Rosary Sign” at Somatostatin Receptor PET in a Case of Recurrent Meningioma by Cesare Michele Iacovitti, Davide Giovanni Bosetti, Barbara Muoio, Marco Cuzzocrea, Gaetano Paone, Giorgio Treglia

Subjects: Get full text

Loss of SynDIG4/PRRT1 alters distribution of AMPA receptors in Rab4- and Rab11-positive endosomes and impairs basal AMPA receptor recycling by Chun-Wei He, Elva Díaz

Subjects: Get full text

Meningioma: Novel Diagnostic and Therapeutic Approaches by Carlen A. Yuen, Michelle Zheng, Max A. Saint-Germain, David O. Kamson

Subjects: Get full text

Pathological complete response of initially unresectable multiple liver metastases achieved using combined peptide receptor radionuclide therapy and somatostatin analogs following... by Ryosuke Umino, Satoshi Nara, Noritoshi Kobayashi, Takahiro Mizui, Takeshi Takamoto, Daisuke Ban, Minoru Esaki, Nobuyoshi Hiraoka, Kazuaki Shimada

Subjects: “…PRRT…”
Get full text

Imaging-derived biomarkers from 68Ga-DOTATOC PET/CT scans to predict survival of patients with neuroendocrine tumors after PRRT with 177Lu-DOTATATE by Stephan Raad, Ali Al-Fatlawi, C. Louise Wise, Christian Fottner, Simin Schadmand-Fischer, Mathias Schreckenberger, Matthias M. Weber, Thomas J. Musholt, Michael Schroeder, Matthias Miederer

Subjects: Get full text

“Cold” Somatostatin Analogs in Neuroendocrine Neoplasms: Decoding Mechanisms, Overcoming Resistance, and Shaping the Future of Therapy by Sara Massironi, Manuela Albertelli, Iderina Hasballa, Piero Paravani, Diego Ferone, Antongiulio Faggiano, Silvio Danese

Subjects: “…peptide receptor radionuclide therapy (PRRT)…”
Get full text

The South Australian 177Lu-DOTATATE peptide receptor radionuclide therapy service: an 11-year review of toxicity, health-related quality of life, and survival by L.M. Altus, J.C. Forster, J. Mercurio, M. Kitchener, N. Corsini, M. Nenke, T. Price, D. Patel, R. Chew, D. Moffat, S. Unger, G. Cehic

Subjects: “…peptide receptor radionuclide therapy (PRRT)…”
Get full text

Peptide receptor radionuclide therapy in the management of neuroendocrine tumors (Neoplasms)*: Fundamentals and salient clinical practice points for medical oncologists by Sandip Basu, Rahul Parghane, Rohit Ranade, Pradeep Thapa, Anant Ramaswamy, Vikas Ostwal, Bhawna Sirohi, Dipanjan Panda, Shailesh V Shrikhande

Subjects: “…peptide receptor radionuclide therapy (prrt)…”
Get full text